Clinical Trial Update: Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on optimizing bevacizumab scheduling with chemotherapy for metastatic colorectal cancer completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-04-12